These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 22745335
1. Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2. Zhang J, Lu M, Zhou F, Sun H, Hao G, Wu X, Wang G. Drug Metab Dispos; 2012 Oct; 40(10):1900-8. PubMed ID: 22745335 [Abstract] [Full Text] [Related]
2. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells. Hien TT, Kim HG, Han EH, Kang KW, Jeong HG. Mol Nutr Food Res; 2010 Jul; 54(7):918-28. PubMed ID: 20077420 [Abstract] [Full Text] [Related]
3. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells. Kanagasabai R, Krishnamurthy K, Druhan LJ, Ilangovan G. J Biol Chem; 2011 Sep 23; 286(38):33289-300. PubMed ID: 21784846 [Abstract] [Full Text] [Related]
4. Reversal of P-glycoprotein-mediated multidrug resistance is induced by mollugin in MCF-7/adriamycin cells. Tran TP, Kim HG, Choi JH, Na MK, Jeong HG. Phytomedicine; 2013 May 15; 20(7):622-31. PubMed ID: 23466342 [Abstract] [Full Text] [Related]
5. 1'S-1'-acetoxyeugenol acetate: a novel phenylpropanoid from Alpinia conchigera enhances the apoptotic effects of paclitaxel in MCF-7 cells through NF-κB inactivation. In LL, Azmi MN, Ibrahim H, Awang K, Nagoor NH. Anticancer Drugs; 2011 Jun 15; 22(5):424-34. PubMed ID: 21346553 [Abstract] [Full Text] [Related]
6. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells. Li C, Guan X, Xue H, Wang P, Wang M, Gai X. Pathol Res Pract; 2017 Jul 15; 213(7):848-853. PubMed ID: 28554760 [Abstract] [Full Text] [Related]
7. Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells. Zhang J, Zhou F, Wu X, Zhang X, Chen Y, Zha BS, Niu F, Lu M, Hao G, Sun Y, Sun J, Peng Y, Wang G. Br J Pharmacol; 2012 Jan 15; 165(1):120-34. PubMed ID: 21615726 [Abstract] [Full Text] [Related]
8. Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro. Li F, Fan J, Wu Z, Liu RY, Guo L, Dong Z, Wang Z. Pharm Biol; 2013 Sep 15; 51(9):1196-203. PubMed ID: 23777360 [Abstract] [Full Text] [Related]
9. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region. Ogretmen B, Safa AR. Biochemistry; 1999 Feb 16; 38(7):2189-99. PubMed ID: 10026303 [Abstract] [Full Text] [Related]
10. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. Weldon CB, Parker AP, Patten D, Elliott S, Tang Y, Frigo DE, Dugan CM, Coakley EL, Butler NN, Clayton JL, Alam J, Curiel TJ, Beckman BS, Jaffe BM, Burow ME. Int J Oncol; 2004 Jun 16; 24(6):1473-80. PubMed ID: 15138590 [Abstract] [Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Int J Oncol; 2004 Mar 16; 24(3):591-608. PubMed ID: 14767544 [Abstract] [Full Text] [Related]
12. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo. Matsumoto G, Namekawa J, Muta M, Nakamura T, Bando H, Tohyama K, Toi M, Umezawa K. Clin Cancer Res; 2005 Feb 01; 11(3):1287-93. PubMed ID: 15709200 [Abstract] [Full Text] [Related]
13. Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition. Yun UJ, Lee JH, Koo KH, Ye SK, Kim SY, Lee CH, Kim YN. Biochem Pharmacol; 2013 May 15; 85(10):1441-53. PubMed ID: 23473805 [Abstract] [Full Text] [Related]
14. Perifosine downregulates MDR1 gene expression and reverses multidrug-resistant phenotype by inhibiting PI3K/Akt/NF-κB signaling pathway in a human breast cancer cell line. Lin X, Zhang X, Wang Q, Li J, Zhang P, Zhao M, Li X. Neoplasma; 2012 May 15; 59(3):248-56. PubMed ID: 22329846 [Abstract] [Full Text] [Related]
15. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells. Xiang W, Gao A, Liang H, Li C, Gao J, Wang Q, Shuang B, Zhang J, Yan Y, Wang X. Toxicol In Vitro; 2010 Sep 15; 24(6):1474-81. PubMed ID: 20656007 [Abstract] [Full Text] [Related]
16. Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation. Kim HG, Hien TT, Han EH, Hwang YP, Choi JH, Kang KW, Kwon KI, Kim BH, Kim SK, Song GY, Jeong TC, Jeong HG. Br J Pharmacol; 2011 Mar 15; 162(5):1096-108. PubMed ID: 21054339 [Abstract] [Full Text] [Related]
17. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage. Fan S, Meng Q, Laterra JJ, Rosen EM. Oncogene; 2007 Jul 19; 26(33):4774-96. PubMed ID: 17297451 [Abstract] [Full Text] [Related]
18. Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells. Manna SK, Gangadharan C. Mol Immunol; 2009 Apr 19; 46(7):1340-50. PubMed ID: 19128834 [Abstract] [Full Text] [Related]
19. Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway. Yang L, Zhang C, Chen J, Zhang S, Pan G, Xin Y, Lin L, You Z. Pharm Biol; 2020 Dec 19; 58(1):276-285. PubMed ID: 32251615 [Abstract] [Full Text] [Related]
20. Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition. Wang L, Meng Q, Wang C, Liu Q, Peng J, Huo X, Sun H, Ma X, Liu K. J Nat Prod; 2013 May 24; 76(5):909-14. PubMed ID: 23621869 [Abstract] [Full Text] [Related] Page: [Next] [New Search]